cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2008; 52:60-68, doi:10.1016/j.jacc.2008.02.077
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lisy, O.
Right arrow Articles by Burnett, J. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lisy, O.
Right arrow Articles by Burnett, J. C., Jr
Related Collections
Right arrowRelated Article

Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP

Ondrej Lisy, MD, PhD*,*, Brenda K. Huntley*, Daniel J. McCormick, PhD{dagger}, Paul A. Kurlansky, MD{ddagger} and John C. Burnett, Jr, MD*

* Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
{dagger} Laboratory of Expression Proteomics and Protein Chemistry, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
{ddagger} Miami Heart Research Institute, Miami, Florida.

Manuscript received December 27, 2007; revised manuscript received February 19, 2008, accepted February 26, 2008.

* Reprint requests and correspondence: Dr. Ondrej Lisy, Cardiorenal Research Laboratory, Guggenheim 9, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905. (Email: lisy.ondrej{at}mayo.edu).

Objectives: Our aim was to design, synthesize and test in vivo and in vitro a new chimeric peptide that would combine the beneficial properties of 2 distinct natriuretic peptides with a biological profile that goes beyond native peptides.

Background: Studies have established the beneficial vascular and antiproliferative properties of C-type natriuretic peptide (CNP). While lacking renal actions, CNP is less hypotensive than the cardiac peptides atrial natriuretic peptide and B-type natriuretic peptide but unloads the heart due to venodilation. Dendroaspis natriuretic peptide is a potent natriuretic and diuretic peptide that is markedly hypotensive and functions via a separate guanylyl cyclase receptor compared with CNP.

Methods: Here we engineered a novel chimeric peptide CD-NP that represents the fusion of the 22-amino acid peptide CNP together with the 15-amino acid linear C-terminus of Dendroaspis natriuretic peptide. We also determined in vitro in cardiac fibroblasts cyclic guanosine monophosphate-activating and antiproliferative properties of CD-NP.

Results: Our studies demonstrate in vivo that CD-NP is natriuretic and diuretic, glomerular filtration rate enhancing, cardiac unloading, and renin inhibiting. CD-NP also demonstrates less hypotensive properties when compared with B-type natriuretic peptide. In addition, CD-NP in vitro activates cyclic guanosine monophosphate and inhibits cardiac fibroblast proliferation.

Conclusions: The current findings advance an innovative design strategy in natriuretic peptide drug discovery and development to create therapeutic peptides with favorable properties that may be preferable to those associated with native natriuretic peptides.

Key Words: peptide • kidney • blood pressure • cGMP • sodium excretion • fibroblasts

Abbreviations and Acronyms
  AA = amino acid
  AHF = acute heart failure
  AMI = acute myocardial infarction
  ANP = atrial natriuretic peptide
  BNP = B-type natriuretic peptide
  BrdU = bromodeoxyuridine
  CF = cardiac fibroblast
  cGMP = cyclic 3'5' guanosine monophosphate
  CNP = C-type natriuretic peptide
  DNP = Dendroaspis natriuretic peptide
  GFR = glomerular filtration rate
  NEP = neutral endopeptidase
  NMP = 1-methyl-2-pyrrolidinone
  PFRNa = proximal fractional sodium reabsorption
  PRA = plasma renin activity


Related Article

From B-Type Natriuretic Peptide to Green Mambas: The Process of Discovery
Gary S. Francis
J. Am. Coll. Cardiol. 2008 52: 69-70. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. M. Dickey, J. C. Burnett Jr., and L. R. Potter
Novel Bifunctional Natriuretic Peptides as Potential Therapeutics
J. Biol. Chem., December 12, 2008; 283(50): 35003 - 35009.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1671 - 1678.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. S. Francis
From B-type natriuretic Peptide to green mambas the process of discovery.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 69 - 70.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home